Versartis (VSAR) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free VSAR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline16 Biopharma Companies Besides Medivation That Are Attractive Targetsthestreet.com - July 21 at 6:58 PMDon't Tell Anyone: Insiders Are Buying These Stocks Like Crazythestreet.com - December 28 at 9:51 AMZluri Hires Todd Dekkinga as Chief Information Security Officer - Yahoo Financefinance.yahoo.com - October 11 at 8:06 AMAscendis Pharma: Biotech Bear Provides Attractive Entry Point - Seeking Alphaseekingalpha.com - May 9 at 6:48 AMVersartis Price Gains on Drug Approval, eHealth Rises: Tech Winners & Losersthestreet.com - March 21 at 10:03 AMAmphista Therapeutics Appoints New Chairman, Joshua T. Brumm - PRNewswireprnewswire.com - September 22 at 9:13 AMCidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary - Yahoo Financefinance.yahoo.com - September 3 at 4:27 AMCidara Therapeutics (CDTX) Appoint Preetam Shah as CFO and CBO, and Shane Ward as Chief Legal Officer and Corporate Secretary - StreetInsider.comstreetinsider.com - September 2 at 2:28 AM3 Biotech Stocks Wall Street Predicts Will Rally by More Than 170% - Entrepreneurentrepreneur.com - July 22 at 7:49 PM Get Versartis News Delivered to You Automatically Sign up to receive the latest news and ratings for VSAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report VSAR Media Mentions By Week VSAR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VSAR News Sentiment▼0.000.33▲Average Medical News Sentiment VSAR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VSAR Articles This Week▼00▲VSAR Articles Average Week Get Versartis News Delivered to You Automatically Sign up to receive the latest news and ratings for VSAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Context Therapeutics News Today LAVA Therapeutics News Today Mainz Biomed News Today NLS Pharmaceutics News Today Pharvaris News Today Procaps Group News Today Qilian International Holding Group News Today Tiziana Life Sciences News Today Aclarion News Today Alpha Tau Medical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VSAR) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Versartis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
